Table 4.
Variables | Willing to receive HPV vaccine | ||
---|---|---|---|
Unadjusted OR (95% CI) | Adjusted OR (95% CI) | P | |
Permanent residence (for more than one year) | |||
Rural | 1 | 1 | |
Urban | 1.56(1.35–1.81) | 1.08(.89–1.30) | .44 |
Living expenses (RMB/month) | |||
<1000 yuan | 1 | 1 | |
1000–2000 yuan | 1.39(1.16–1.66) | .90(.73–1.11) | .32 |
2001–3000 yuan | 2.56(1.92–3.41) | .93(.66–1.32) | .70 |
>3000 yuan | 5.19(2.58–10.44) | 2.18(.97–4.92) | .06 |
Education level of parents | |||
Junior high school or below | 1 | 1 | |
Senior high school ( including vocational high school) | 1.33(1.13–1.57) | .96(.79–1.16) | .66 |
College (including technical college) and above | 1.69(1.43–2.00) | .87(.69–1.09) | .21 |
Previous sexual experience | |||
No | 1 | 1 | |
Yes | 2.63(1.79–3.86) | 1.96(1.25–3.08) | .00** |
Currently relationship | |||
No | 1 | 1 | |
Yes | 1.43(1.20–1.70) | 1.10(.90–1.35) | .35 |
Family or friends with any cancer (including cervical cancer) | |||
No | 1 | 1 | |
Yes | 1.52(1.30–1.77) | 1.24(1.04–1.48) | .02* |
Vaccination is effective in preventing disease | |||
No | 1 | 1 | |
Yes | 1.41(1.06–1.87) | .91(.66–1.25) | .55 |
Ever received sexual education | |||
No | 1 | 1 | |
Yes | 1.72(1.44–2.06) | 1.14(.93–1.39) | .22 |
Attitude toward premarital sex | |||
Con | 1 | 1 | |
Pro | 1.54(1.34–1.77) | 1.06(.90–1.25) | .51 |
Ever heard of HPV | |||
No | 1 | 1 | |
Yes | 2.05(1.77–2.37) | 1.23(1.03–1.47) | .03* |
Ever actively searched for or consulted on HPV vaccination | |||
No | 1 | 1 | |
Yes | 2.31(2.00–2.66) | 1.22(1.02–1.45) | .03* |
Information | 1.12(1.09–1.15) | 1.01(.97–1.04) | .73 |
Motivation | 1.01(.97–1.04) | .73 | |
Perceived susceptibility | 1.31(1.22–1.42) | 1.20(1.09–1.31) | .00** |
Perceived severity | 1.11(1.01–1.21) | 1.24(1.11–1.39) | .00** |
Perceived benefits | 1.82(1.61–2.06) | .86(.73–1.00) | .05 |
Perceived barriers | .46(.41–.52) | .60(.52–.69) | .00** |
Subjective norms | 3.90(3.32–4.57) | 2.09(1.75–2.49) | .00** |
Behavioral skills | |||
Decision-making | 1.56(1.38–1.77) | .86(.74–1.01) | .06 |
Self-efficacy | 4.54(3.94–5.24) | 2.95(2.44–3.58) | .00** |
*P < .05; **P < .01. Abbreviation: HPV, human papillomavirus.